News | Artificial Intelligence | November 18, 2019

Visage to Spotlight the Visage 7 Enterprise Imaging Platform at RSNA

The company will demonstrate the imaging platform in a new 3,200 sq. ft. booth in the North Hall, McCormick Place

November 18, 2019 — Visage Imaging, Inc. (Visage), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has announced Visage will be exhibiting under the theme of "Platform for the Future—Powered by Speed," highlighted by the demonstration of the Visage 7 Enterprise Imaging Platform, at the Radiological Society of North America (RSNA) 2019 annual meeting (Visage Booth 7524, McCormick Place-North Hall), Dec. 1-5, in Chicago, Ill.

Visage 7 has advanced Enterprise Imaging based on the proven ability to replace legacy PACS for imaging organizations of all sizes and local, regional or national scale. Five of the 2019-2020 top 20 ranked U.S. hospitals have chosen Visage 7, more than any other PACS.

One of the key drivers of this change has been the relentless growth of datasets produced by modern imaging modalities such as large cross-sectional (CT/MR) and digital breast tomosynthesis (DBT), and now high-resolution DBT ("High-res DBT"). These datasets, which are often combined with numerous prior imaging studies, are creating major bottlenecks for legacy 'compress and send' technology.

"The challenges of data explosion are placing significant stress on healthcare institutions, particularly when it comes to imaging," explained Malte Westerhoff, PhD, Visage Imaging Co-Founder and Chief Technology Officer. Westerhoff continued, "While we'll continue to successfully scale the underlying platform to cope with the exponentially growing compute and data handling requirements, that is only one part of the solution. Continuous innovation in how the system can aid and guide users in understanding data quickly, efficiently and reliably is also needed to allow users to benefit from the additional resolution and information contained in these growing datasets, instead of slowing them down. This involves user interface enhancements, AI-based data analysis and seamless information exchange with other IT systems in the modern enterprise."

At RSNA 2019, the following highlights will be demonstrated and discussed:

  • High-res DBT. Visage 7 supports the diagnostic interpretation of high-res DBT, delivered on-demand and in real-time, by ultrafast server-side processing.
  • Ophthalmology. With One Viewer, Visage 7 now supports even more clinical data, including PDF documents and ophthalmology images, enabling the elimination of legacy ophthalmology PACS.
  • Go-live flexibility. A Visage exclusive, Visage 7 enables customers to go-live enterprise-wide, assembling the imaging patient jacket on-the-fly with all priors, even if customer data migration is incomplete, from one or multiple PACS.
  • Breast MR multiparametric color maps. A preview of capabilities projected for Visage 7.1.15 will be demonstrated, including Breast MR multiparametric color maps for diffusion-weighted imaging as a works-in-progress (WIP). Visage 7 will be demonstrated with native, specialized toolsets for calculation and color mapped visualization of kinetic information in Breast MR images with elastic registration. 
  • Visage AI Accelerator. Visage will introduce the Visage AI Accelerator, an end-to-end AI solution that bridges both research and diagnostic imaging with the same, unified platform (WIP).
  • Visage 7 in the cloud. Highly optimized for cloud deployment, Visage 7 is the industry's first cloud-engineered server-side platform for complete PACS operations. Visage 7 in the cloud can offer the same ultrafast speed and functionality of on-premise implementations, but with the added security and scale of the cloud.
  • Visage 7 Workflow. Visage 7 now offers integrated, native workflow enabling customers to unify and manage reading worklists. Customers now have the choice of driving their reading workflow from independent workflow platforms, EHR-driven workflow, or natively with Visage 7.

Visage will be exhibiting in a new 3,200 sq. ft. booth in the North Hall, McCormick Place. To schedule a priority demonstration of Visage 7 or to meet with Visage at RSNA 2019, please visit this link for additional details.

For more information: www.visageimaging.com

Related Content

Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
he U.S. Food and Drug Administration (FDA) has issued a final order to reclassify medical image analyzers applied to mammography breast cancer, ultrasound breast lesions, radiograph lung nodules and radiograph dental caries detection, postamendments class III devices (regulated under product code MYN), into class II (special controls), subject to premarket notification

Image courtesy of iCAD

News | Computer-Aided Detection Software | January 22, 2020
January 22, 2020 — The U.S.
Medical imaging technology company Oxipit announced partnership with Swiss medical distribution company Healthcare Konnect to bring ChestEye AI imaging suite to healthcare institutions in Nigeria
News | Artificial Intelligence | January 22, 2020
January 22, 2020 — Medical imaging technology company Oxipit ann
Hitachi Healthcare Americas announced that it will create a new dedicated research and development facility within its North American headquarters facility in Twinsburg, Ohio
News | Radiology Business | January 21, 2020
January 21, 2020 — Hitachi Healthcare Americas announced that it will create a new dedicated research and development
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...
Sponsored Content | Videos | Enterprise Imaging | January 20, 2020
GE Healthcare's iCenter is a cloud-based management software that provides 24/7 visibility to customers' visual and o
This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.   #RSNA #

This is a lung X-ray reviewed automatically by artificial intelligence (AI) to identify a collapsed lung (pneumothorax) in the color coded area. This AI app from Lunit is awaiting final FDA review and in planned to be integrated into several vendors' mobile digital radiography (DR) systems. Fujifilm showed this software integrated as a work-in-progress into its mobile X-ray system at RSNA 2019. GE Healthcare has its own version of this software for its mobile r=ray systems that gained FDA in 2019.

Feature | RSNA | January 20, 2020 | Dave Fornell, Editor
Here are images of some of the newest new medical imaging technologies displayed on the expo floor at the ...
Konica Minolta Business Solutions, U.S.A., Inc. (Konica Minolta) announced its status as a Google Cloud Premier Partner.
News | Archive Cloud Storage | January 14, 2020
January 14, 2020 — ...